id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-347151-ni94qi4r	Vespa, Edoardo	Liver tests abnormalities in COVID-19: trick or treat?	2020-05-27		.txt	text/plain	690	45	57	We read with interest the recent study by Cai et al [1] , which describes the role of liver function tests (LFTs) in a population of hospitalized patients with COVID-19. This data is in line with other studies which reported a high prevalence of LFTs abnormalities in Covid-19 but failed to demonstrate an association with worse outcomes [3] . Interestingly, our observation on the clinical value of ALP as a marker of poor prognosis is in contrast with the finding by Cai and colleagues that the risk of progression to severe disease was associated with hepatocellular (AST and/or ALT >3 ULN) or mixed (a combination of AST/ALT >3 ULN and ALP/GGT >2 ULN) pattern of LFTs elevation, rather than a cholestatic pattern. In conclusion, we think that although LFTs alterations are common in hospitalized Covid-19 patients, it is still unclear whether they carry any prognostic value. Clinical characteristics of non-ICU hospitalized patients with coronavirus disease 2019 and liver injury: A retrospective study	./cache/cord-347151-ni94qi4r.txt	./txt/cord-347151-ni94qi4r.txt